Category: MS Drug Therapies

FDA Approves Ponvory (ponesimod) For Adults With Relapsing Forms of MS

 FDA APPROVED       Ponesimod Medication Description Description Ponesimod, sold under the brand name Ponvory, is a medication for…

Stuart Schlossman

Cladribine Personalized Dosing Well Tolerated and Efficacious in Multiple Sclerosis

Researchers found that 22 of 23 patients with elevated CSF NfL at baseline had normal levels at 2-year follow-up. Kimberly…

Stuart Schlossman

Listing of (14) MS educational Talks (Symptom related and more) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)- by @NeurologyLIVE

encephalitis. CNM-Au8 Displays Positive Interim Results in Multiple Sclerosis February 28, 2021 ByMatt Hoffman Clene Nanomedicine’s nanocatalyst agent CNM-Au8 displayed…

Stuart Schlossman

If you are a Bristol Myers Squibb (BMS) patient and lost your job and health insurance due to the COVID-19 pandemic, ,,,

During these challenging times, if you are a U.S. BMS patient and lost your job and health insurance due to the…

Stuart Schlossman

FDA Approves Peginterferon Beta-1a Intramuscular Injection for Relapsing Multiple Sclerosis

Click HERE to Subscribe for the MS Beacon Newsletter February 1, 2021 Marco Meglio The basis of the approval for…

Stuart Schlossman

Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Neurology . 2020 Dec 28;10.1212/WNL.0000000000011242.  doi: 10.1212/WNL.0000000000011242. Online ahead of print. Click HERE to Subscribe for the MS Beacon Newsletter PMID: 33372028  …

Stuart Schlossman

Mayzent Aids Cognitive Processing Speed in SPMS Patients, Trial Suggests

Click HERE to Subscribe for the MS Beacon Newsletter Mayzent (siponimod) significantly improved cognitive processing speed in people with secondary progressive multiple…

Stuart Schlossman

FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis

Click HERE to Subscribe for the MS Beacon Newsletter ·        Approval based on data from the randomized, double-blind ENSEMBLE PLUS…

Stuart Schlossman

Learn of VUMERITY® (diroximel fumarate)

What is VUMERITY® (diroximel fumarate)? VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS),…

Stuart Schlossman

Some MS Drugs Linked With Worse COVID-19 Outcomes

— Registry data looks at risks of hospitalization, ICU admission, ventilation by Judy George, Senior Staff Writer, MedPage Today September 28, 2020…

Stuart Schlossman

Categories

Latest Blog Posts